DiaMedica Therapeutics Inc. Common Stock

$0.00 (0.00%) As of 1:24 PM UTC pre-market

Why Robinhood?

You can buy or sell DMAC and other stocks, options, and ETFs commission-free!

About DMAC

DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD).

CEO
Rick John Pauls
Employees
11
Headquarters
Minneapolis, Minnesota
Founded
2000

DMAC Key Statistics

Market Cap
148.66M
Price-Earnings Ratio
Dividend Yield
Average Volume
154.97K
High Today
$7.98
Low Today
$7.43
Open Price
$7.98
Volume
215.84K
52 Week High
$10.88
52 Week Low
$3.77

DMAC Earnings

-$0.23
-$0.15
-$0.08
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure